Isolated lung prefusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma (vol 66, pg 1719, 1998)

被引:0
|
作者
Hendriks, JMH
Van Schil, PEY
De Boeck, G
Lauwers, PRM
Van Oosteram, AT
Van Marck, EAE
Eyskens, EJM
机构
来源
ANNALS OF THORACIC SURGERY | 1998年 / 66卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2164 / 2164
页数:1
相关论文
共 22 条
  • [1] Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma
    Hendriks, JMH
    Van Schil, PEY
    De Boeck, G
    Lauwers, PRM
    Van Oosterom, AAT
    Van Marck, EAE
    Eyskens, EJM
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (05): : 1719 - 1724
  • [2] Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma - Discussion
    Todd, TRJ
    Kaiser, LR
    Hendriks, JMH
    LoCicero, J
    Ris, HB
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (05): : 1724 - 1725
  • [3] Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma
    Hendriks, JMH
    Van Schil, PEY
    Van Oosterom, AAT
    Kuppen, PJK
    Van Marck, E
    Eyskens, E
    [J]. EUROPEAN SURGICAL RESEARCH, 1999, 31 (03) : 267 - 271
  • [4] Isolated lung perfusion with tumor necrosis factor for pulmonary metastases
    Pass, HI
    Mew, DJY
    Kranda, KC
    Temeck, BK
    Donington, JS
    Rosenberg, SA
    [J]. ANNALS OF THORACIC SURGERY, 1996, 61 (06): : 1609 - 1617
  • [5] Isolated lung perfusion with tumor necrosis factor for pulmonary metastases - Discussion
    Miller, DL
    Pass, HI
    Krasna, MJ
    [J]. ANNALS OF THORACIC SURGERY, 1996, 61 (06): : 1617 - 1617
  • [6] Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessments
    Sleijfer, S
    vanGinkel, RJ
    vanderMark, TW
    Hoekstra, HJ
    Zwaveling, JH
    Koops, HS
    Mulder, NH
    [J]. JOURNAL OF IMMUNOTHERAPY, 1997, 20 (03): : 202 - 207
  • [7] A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver
    Alexander, HR
    Libutti, SK
    Bartlett, DL
    Puhlmann, M
    Fraker, DL
    Bachenheimer, LC
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3062 - 3070
  • [8] Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice (vol 801, pg 1, 1998)
    Gong, C
    Qin, Z
    Betz, AL
    Liu, XH
    Yang, GY
    [J]. BRAIN RESEARCH, 1999, 818 (01) : 184 - 184
  • [9] Tumor necrosis factor is not required for particle-induced genotoxicity and pulmonary inflammation (vol 79, pg 177, 2005)
    Saber, AT
    Bornholdt, J
    Dybdahl, M
    Sharma, AK
    Loft, S
    Vogel, U
    Wallin, H
    [J]. ARCHIVES OF TOXICOLOGY, 2005, 79 (06) : 363 - 363
  • [10] Monitoring system for isolated lung perfusion with tumor necrosis factor-α and Melphalan based on 99mTc-labelled RBC and surgical probe: Initial experience
    Villa, Giuseppe
    Ratto, Giovanni
    Elena, Pomposelli
    Fiz, Francesco
    Sambuceti, Gianmario
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52